$ASTS  and $RKLB have both pulled back recently, but for very different reasons. $ASTS slid on concerns around TeraWave, while $RKLB dropped after the Neutron test tank rupture, with broader macro pressure not helping either. At these levels, the question feels less about “which is better” and more about timing and risk tolerance. $ASTS looks tied to execution and regulatory clarity, while $RKLB’s story hinges on technical progress and recovery from setbacks. It’s not hard to argue for either as a dip buy, but it’s also reasonable to wait if volatility continues and headlines stay heavy.